A 67-year-old woman receiving tumor necrosis factor α inhibitor therapy presenting with neurologic dysfunction

Arthritis Care Res (Hoboken). 2013 Apr;65(4):658-65. doi: 10.1002/acr.21882.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Cognition Disorders / chemically induced*
  • Cognition Disorders / diagnosis
  • Diagnosis, Differential
  • Female
  • Humans
  • Infliximab
  • Magnetic Resonance Imaging
  • Paresthesia / chemically induced*
  • Paresthesia / diagnosis
  • Tomography, X-Ray Computed
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab